What they were paid
Crinetics Pharmaceuticals Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $81,750 | $223,077 | $202,515 | $0 | $507,342 |
| FY2024 | $58,000 | $152,014 | $341,750 | — | $551,764 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Crinetics Pharmaceuticals, Inc. DEF 14A filed April 29, 2026, accession 0001658247-26-000030, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themAudit · Research and Development · Global Therapeutics Strategy and Access (Chair)
The rest of the Crinetics Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Camille Bedrosian, M.D | Independent Director | $500,467 |
| Caren Deardorf | Independent Director | $485,467 |
| Matthew K. Fust | Independent Director | $498,592 |
| R. Scott Struthers, Ph.D | Director | $0 |
| Stephanie S. Okey, M.S | Independent Director | $500,467 |
| Wendell Wierenga, Ph.D | Chair of the Board | $528,617 |
| Weston Nichols, Ph.D | Independent Director | $493,844 |
The full Crinetics Pharmaceuticals compensation record
free company briefThis page is one director within Crinetics Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat